New trends in aortic valve surgery
Authors:
A. Mokráček
Authors place of work:
České Budějovice
; Kardiochirurgické oddělení Nemocnice
Published in the journal:
Kardiol Rev Int Med 2013, 15(3): 144-148
Category:
Chlopenní vady
Summary
New trends in aortic valve surgery. This article presents some aspects and new trends in the surgery of aortic valve stenosis. We focused particularly on the limits of the standard procedures from median sternotomy and the possible alternative solutions. It means partial sternotomy and minithoracotomy, sutureless valves, transcatheter valves without extracorporeal circulation and new trends in monitoring of anticoagulation.
Keywords:
aortic valve – aortic valve replacement – sutureless – transcatheter heart valve
Zdroje
1. Roberts WC. Valvular, subvalvular and supravalvular aortic stenosis: morphologic features. Cardiovasc Clin 1973; 5: 97– 126.
2. Ross J Jr, Braunwald E. Aortic stenosis. Circulation 1968; 38 (1 Suppl): 61– 67.
3. Brown ML, McKellar SH, Sundt TM et al. Ministernotomy versus conventional sternotomy for aortic valve replacement: a systematic rewiew and meta‑analysis. J Thorac Cardiovasc Surg 2009; 137: 670– 679.
4. Santana O, Reyna J, Benjo AM et al. Outcomes of minimally invasive valve surgery in patiens with chronic obstructive pulmonary disease. Eur J Cardiothorac Surg 2012; 42: 648– 652.
5. Glauber M, Miceli A, Bevilacqua S et al. Minimally invasive aortic valve replacement via right anterior minithoracotomy: early outcomes and midterm follow‑up. J Thorac Cardiovasc Surg 2011; 142: 1577– 1579.
6. Mokráček A, Čanádyová J, Kurfirst V et al. Bezstehové aortální bioprotézy, první zkušenost s protézou Sorin Perceval S. Interv Akut Kardiol 2013; 12: 121– 123.
7. Lung B, Baron G, Butchart EG et al. A prospective survey of patiens with valvular heart disease in Europe: The Euro heart survey on valvular heart disease. Eur Heart J 2003; 24: 1231– 1243.
8. Brown ML, Pellikka PA, Schaff HV et al. The benefits of early valve replacement in asymptomatic patiens with severe aortic stenosis. J Thorac Cardiovasc Surg 2008; 135: 308– 315.
9. Bouma BJ, van Den Brink RB, van Der Meulen JH et al. To operate or not on eldery patiens with aortic stenosis: the decision and its consequences. Heart 1999; 82: 143– 148.
10. Baraki H, Al Ahmad A, Jeng- Singh S et al. Pacemaker dependancy after isolated aortic valve replacement: do conductance disorders recover over time? Interact Cardiovasc Thorac Surg 2013; 16: 476– 481.
11. Haensig M, Lehmkuhl L, Rastan AJ et al. Aortic valve calcium scoring is a predictor of significant paravalvular aortic insufficiency in transapical- aortic valve implantation. Eur J Cardiothorac Surg 2012; 41: 1234– 1240.
12. Osnabrugge RL, Head SJ, Genders TS et al. Costs of transcatether versus surgical aortic valve replacement in intermediate- risk patiens. Ann Thorac Surg 2012; 94: 1954– 1960.
13. Horstkotte D, Schulte H, Bircks W et al. Unexpected findings concerning thromboembolic complications and anticoagulation after complete 10 year follow up of patients with St. Jude Medical prostheses. J Heart Valve Dis 1993; 2: 291– 301.
14. Clinical communiqué: 16 year results. Carpentier- Edwards Perimount Mitral Pericardial Bioprosthesis. Available from: http:/ / ht.edwards.com/ resourcegallery/ products/ heartvalves/ pdfs/ clinicalcommuniquemitral.pdf.
15. Edwards FH, Peterson ED, Coombs LP et al. Prediction of operative mortality after valve replacement surgery. J Am Coll Cardiol 2001; 37: 885– 892.
16. Yap KH, Murphy R, Devbhandari M et al. Aortic valve replacement: is porcine or bovine valve better? Interact Cardiovasc Thorac Surg 2013; 16: 361– 373.
17. Del Rizzo DF, Abdoh A, Cartier P et al. The effect of prosthetic valve type on survival after aortic valve surgery. Semin Thorac Cardiovasc Surg 1999; 11 (4 Suppl 1): 1– 8.
18. Bach DS, Metras J, Doty JR et al. Freedom from structural valve deterioration among patients agend < or = 60 years undergoing Freestyle stentless aortic valve replacement. J Heart Valve Dis 2007; 16: 649– 655.
19. Bach DS, Goldman B, Verrier E et al. Durability and prevalence of aortic regurgitation nine years after aortic valve replacement with the Toronto SPV stentless bioprosthesis. J Heart Valve Dis 2004; 13: 64– 72.
20. Nash PJ, Vitvitsky E, Li J et al. Feasibility of valve repair for regurgitant bicuspid aortic valves – an echocardiographic study. Ann Thorac Surg 2005; 79: 1473– 1479.
21. Horstkotte D, Piper C. Improvement of oral anticoagulation therapy by INR self- management. J Heart Valve Dis 2004; 13: 335– 338.
22. Sidhu P, O’Kane KO. Self- managed anticoagulation: results from a two‑year prospective randomized trial with heart valve patiens. Ann Thorac Surg 2001; 72: 1523– 1527.
23. Uekermann J, Suchan B, Daum I et al. Neuropsychological deficits after mechanical aortic valve replacement. J Heart Valve Dis 2005; 14: 338– 343.
24. Geiser T, Sturzenegger M, Genewein U et al. Mechanisms of cerebrovascular events as assessed by procoagulant activity, cerebral microemboli, and platelet microparticles in patients with prosthetic heart valves. Stroke 1998; 29: 1770–1777.
25. Kaps M, Hansen J, Weiher M et al. Clinically silent microemboli in patiens with artificial prosthetic aortic valves are predominantly gaseous and not solid. Stroke 1997; 28: 322– 325.
26. Gencbay M, Degertekin M, Basaran Y et al. Microbubbles associated with mechanical heart valves: their relation with serum lactic dehydrogenace levels. Am Heart J 1999; 137: 463– 468.
27. Skoularigis J, Essop MR, Skudicky D et al. Frequency and severity of intravascular hemolysis after left- sided cardiac valve replacement with Medtronic Hall and St. Jude Medical prostheses, and influence of prosthetic type, position, size and number. Am J Cardiol 1993; 71: 587– 591.
28. Georgiadis D, Braun S, Uhlmann F et al. Doppler microembolic signals in patients with two different types of bileaflet valves. J Thorac Cardiovasc Surg 2001; 121: 1101–1106.
Štítky
Dětská kardiologie Interní lékařství Kardiochirurgie KardiologieČlánek vyšel v časopise
Kardiologická revue – Interní medicína
2013 Číslo 3
- Není statin jako statin aneb praktický přehled rozdílů jednotlivých molekul
- Testování hladin NT-proBNP v časné diagnostice srdečního selhání – guidelines ESC
- Cinitaprid – v Česku nová účinná látka nejen pro léčbu dysmotilitní dyspepsie
Nejčtenější v tomto čísle
- Diagnostika aortální stenózy
- Extrasystoly – Arytmie a možnosti léčby v kontextu chlopenních vad
- Katetrizační implantace aortální chlopně (TAVI) – současnost a novinky v roce 2013
- Nové směry v chirurgické léčbě aortální stenózy